International Journal of Particle Therapy

Scope & Guideline

Exploring Breakthroughs in Particle Therapy Research

Introduction

Delve into the academic richness of International Journal of Particle Therapy with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherINT JOURNAL PARTICLE THERAPY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationINT J PART THER / Int. J. Part. Ther.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2000 SW ARCHER RD, GAINESVILLE, FL 32610, UNITED STATES

Aims and Scopes

The *International Journal of Particle Therapy* focuses on advancing the field of particle therapy, particularly proton and carbon ion therapies, through innovative research and clinical studies. It aims to provide a platform for disseminating knowledge on various aspects of particle therapy, including treatment outcomes, dosimetry, and technological advancements.
  1. Clinical Applications of Particle Therapy:
    The journal emphasizes research on the clinical applications of proton and carbon ion therapies across various cancer types, assessing their effectiveness and safety compared to traditional photon therapies.
  2. Radiobiological Studies:
    It investigates the radiobiological mechanisms underlying particle therapy, exploring how different radiation types affect tumor and normal tissue responses.
  3. Technological Innovations and Methodologies:
    The journal covers advancements in treatment planning, delivery techniques, and imaging methods that enhance the precision and efficacy of particle therapy.
  4. Patient Outcomes and Quality of Life:
    Research on long-term patient outcomes, including survivorship, quality of life, and toxicity profiles associated with particle therapy, is a core focus.
  5. Health Economics and Accessibility:
    The journal also addresses the economic aspects of particle therapy, including cost-effectiveness analyses and accessibility issues for patients.
The *International Journal of Particle Therapy* has shown a clear evolution in its focus areas, with several emerging themes gaining traction in recent years. These trends indicate the journal's responsiveness to advancements in the field and current research priorities.
  1. Artificial Intelligence and Machine Learning in Treatment Planning:
    There is a growing trend towards integrating artificial intelligence and machine learning techniques in treatment planning and optimization for particle therapy, highlighting the role of technology in enhancing precision and outcomes.
  2. Personalized Medicine Approaches:
    Research is increasingly focusing on personalized medicine, tailoring particle therapy based on individual patient characteristics and tumor biology to improve treatment efficacy.
  3. Longitudinal Studies on Outcomes and Toxicity:
    Emerging studies are emphasizing long-term follow-up and the assessment of late toxicities associated with particle therapy, indicating a shift towards understanding the long-term impacts of treatments.
  4. Combination Therapies:
    There is a rising interest in exploring combination therapies that integrate particle therapy with immunotherapy, chemotherapy, or targeted therapies, aiming for synergistic effects in cancer treatment.
  5. Patient-Centered Care and Quality of Life Studies:
    Research focusing on patient-centered outcomes, including quality of life assessments and patient-reported outcomes, is becoming increasingly prominent, reflecting a holistic approach to cancer care.

Declining or Waning

While the journal continues to thrive in many areas, certain themes appear to be declining in prominence based on recent publications. These waning themes may reflect shifts in research priorities or advancements in other methodologies.
  1. Traditional Radiotherapy Comparisons:
    Research comparing particle therapy with traditional photon therapies has decreased, possibly due to a growing consensus on the advantages of particle therapies, leading to less need for comparative studies.
  2. Non-oncological Applications:
    There has been a noticeable decline in studies focusing on non-oncological applications of particle therapy, such as its use in benign conditions, which may have been overshadowed by more pressing oncological research.
  3. Earlier Historical Perspectives:
    Papers focusing on historical reviews of particle therapy have become less common, as the field moves towards more contemporary and forward-looking research.

Similar Journals

CANCER BIOLOGY & THERAPY

Leading the charge in cancer research and patient care.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4047Frequency: 12 issues/year

CANCER BIOLOGY & THERAPY is a premier open-access journal published by Taylor & Francis Inc, dedicated to advancing the field of cancer research and treatment. Since its inception in 2002, the journal has evolved to provide a platform for innovative research and groundbreaking findings, addressing critical aspects of cancer biology, pharmacology, and molecular medicine. With an impressive impact factor and recognition as a Q2 journal in vital categories such as Cancer Research, Oncology, and Pharmacology, it holds significant standing in Scopus rankings, reflecting its influence and commitment to disseminating high-quality research. Offering researchers, professionals, and students a wealth of knowledge, CANCER BIOLOGY & THERAPY stands at the forefront of the fight against cancer, presenting the latest developments and therapeutic strategies vital for improving patient outcomes. Accessible to all since 2022, this journal is a must-read for anyone involved in the multifaceted arena of cancer research and treatment.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Advancing Knowledge in Radiation Biology
Publisher: TAYLOR & FRANCIS LTDISSN: 0955-3002Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, published by Taylor & Francis Ltd, has established itself as a premier forum for the dissemination of innovative research related to radiation biology, covering emerging topics that are crucial within the fields of radiology, nuclear medicine, and ultrasound technology. With an ISSN of 0955-3002 and an E-ISSN of 1362-3095, this journal spans over six decades, from its inception in 1959 to 2024, reflecting a rich history of scholarly contribution and a dynamic approach to addressing current challenges in the discipline. Its reputation is highlighted by its Q2 rankings in both Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology for 2023, underscoring its relevance in a competitive academic landscape, with Scopus rankings placing it in the top tier of its category. While operating under a traditional access model, the journal aims to connect researchers, professionals, and students, facilitating the advancement of knowledge and fostering a deeper understanding of the impact of radiation in various medical applications. The journal plays an essential role in shaping future research directions and enhancing clinical practices globally.

Radiation Oncology

Empowering oncology with open access to groundbreaking research.
Publisher: BMCISSN: Frequency: 1 issue/year

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

EPJ Techniques and Instrumentation

Empowering researchers through open access to cutting-edge methodologies.
Publisher: SPRINGERISSN: 2195-7045Frequency: 1 issue/year

EPJ Techniques and Instrumentation is a leading journal published by Springer that focuses on advancing the field of instrumentation and measurement techniques across various disciplines. With a commitment to open access since 2014, this journal ensures that the latest research is freely available to academics, providing an inclusive platform for the dissemination of innovative methodologies and technological advancements. The journal serves as an essential resource for researchers, professionals, and students dedicated to the development and application of cutting-edge techniques in their respective fields. While the journal's scope encompasses a wide range of topics, it consistently encourages interdisciplinary collaboration and the exchange of ideas. As a cornerstone publication in the scientific community, EPJ Techniques and Instrumentation is poised to impact the trajectory of future research, fostering a deeper understanding and better utilization of instrumentation in scientific inquiry.

MEDICAL PHYSICS

Unveiling Breakthroughs in Medical Physics Since 1974
Publisher: WILEYISSN: 0094-2405Frequency: 12 issues/year

MEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.

PHYSICS IN MEDICINE AND BIOLOGY

Fostering Collaboration in Medical Physics and Bioengineering
Publisher: IOP Publishing LtdISSN: 0031-9155Frequency: 24 issues/year

PHYSICS IN MEDICINE AND BIOLOGY is a prestigious journal published by IOP Publishing Ltd, with a storied history dating back to 1956 and extending through 2024. This internationally recognized journal caters to the interdisciplinary fields of medical physics and bioengineering, making significant contributions to the research and development of advanced diagnostic and therapeutic technologies. It holds an impressive Q1 ranking in both Radiological and Ultrasound Technology and Radiology, Nuclear Medicine and Imaging categories, reflecting its critical role in disseminating high-quality research. With a significant focus on merging the principles of physics with advancements in medicine, PHYSICS IN MEDICINE AND BIOLOGY serves as an essential resource for researchers, professionals, and students alike, fostering innovation and enhancing collaboration in the healthcare sector. Although the journal is not currently open access, it maintains robust participation in the Scopus database, ranking #62 out of 333 in Radiology, Nuclear Medicine and Imaging and #17 out of 63 in Radiological and Ultrasound Technology, signifying its influence and reach within these disciplines.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Catalyzing Discoveries in Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0277-3732Frequency: 12 issues/year

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of oncology and cancer research, focusing on the latest advancements in clinical trials and therapeutic strategies for cancer management. With an ISSN of 0277-3732 and an E-ISSN of 1537-453X, this journal serves as an essential resource for the dissemination of high-quality research findings, scholarly reviews, and innovative methodologies, aiming to advance clinical oncology from 1982 to 2024. It is categorized in Q3 for Cancer Research and Q2 for Oncology, reflecting its significant role in the scientific community. In addition to its rigorous peer-reviewed content, the journal provides a platform for researchers and clinicians to share valuable insights, laying the groundwork for future breakthroughs in cancer treatment. Although it currently does not offer open-access options, the journal remains accessible to a wide audience through academic institutions and libraries. The AMERICAN JOURNAL OF CLINICAL ONCOLOGY is crucial for anyone involved in oncology research, making it a must-read for professionals dedicated to improving cancer care.

Radiology and Oncology

Pioneering research at the intersection of radiology and oncology.
Publisher: SCIENDOISSN: 1318-2099Frequency: 4 issues/year

Radiology and Oncology is a prominent open access journal that has been instrumental in advancing the fields of radiology and oncology since its inception in 1992. Published by SCIENDO in Germany, this journal aims to disseminate high-quality research articles, reviews, and case studies that address critical issues in diagnostic imaging and cancer treatment. As of 2023, it holds a commendable impact factor within the Q2 category for Radiology, Nuclear Medicine, and Imaging, and a Q3 standing in the field of Oncology—reflecting its importance in these critical areas of medicine. With a focus on promoting innovative research and interdisciplinary collaboration, Radiology and Oncology is indexed in Scopus, where it ranks #122 among 333 in its category and #187 among 404 in Oncology, showcasing its wide-reaching impact and relevance. The journal is fully open access since 2007, ensuring that vital research is accessible to the global medical community and fostering advancements in patient care strategies and therapeutic methodologies. By providing a platform for the latest developments and discoveries, Radiology and Oncology is a pivotal resource for researchers, clinicians, and students dedicated to improving outcomes in cancer care through innovative imaging techniques.

PROSTATE CANCER AND PROSTATIC DISEASES

Innovating research for better prostate cancer care.
Publisher: SPRINGERNATUREISSN: 1365-7852Frequency: 4 issues/year

PROSTATE CANCER AND PROSTATIC DISEASES, published by SpringerNature, is a prestigious international journal dedicated to advancing knowledge in the fields of cancer research, oncology, and urology, as evidenced by its Q1 rankings in 2023. Established in 1997, this journal has become a vital resource for researchers, clinicians, and healthcare professionals, offering impactful research and clinical insights on prostate health and disease. With its focus on innovative studies and comprehensive reviews, it addresses critical challenges in the management and treatment of prostate cancer, driving improvements in patient care globally. The journal's standing is further supported by its impressive Scopus rankings, placing it in the top tier of its categories. Readers can access high-quality, peer-reviewed articles that contribute significantly to ongoing medical practices and improve therapeutic strategies for prostate-related health issues.

Medical Dosimetry

Bridging Theory and Practice in Dosimetry
Publisher: ELSEVIER SCIENCE INCISSN: 0958-3947Frequency: 4 issues/year

Medical Dosimetry is a distinguished journal published by Elsevier Science Inc, dedicated to the advancing field of medical dosimetry and its applications within oncology, radiology, and nuclear medicine. With its ISSN 0958-3947 and E-ISSN 1873-4022, this journal serves as a crucial resource for researchers and professionals aiming to enhance their understanding of radiation treatment planning and dosage calculations. Encompassing a comprehensive range of topics from clinical dosimetry to technology assessment, Medical Dosimetry has been disseminating significant findings since its establishment in 1988, contributing to the continuous development of best practices in patient care and safety. The journal currently holds a Q3 ranking in various categories, reflecting its pivotal role in the research community, while not currently offering open access, it remains an essential reference for scholars advancing the techniques utilized in medical imaging and treatment. By fostering a platform for high-quality research, it aims to bridge the gap between theoretical studies and clinical applications, making it a vital addition to any medical library.